Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk
This study has been completed.
Sponsor:
University of South Carolina
Collaborator:
National Institute of Nursing Research (NINR)
Information provided by (Responsible Party):
University of South Carolina
ClinicalTrials.gov Identifier:
NCT01377064
First received: June 8, 2011
Last updated: December 10, 2013
Last verified: December 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Because of advances in drug treatment, people living with HIV/AIDS (PLWHA) are living longer, but are also at greater risk for cardiovascular disease (CVD) and diabetes. Exercise and increased physical activity can reduce the risk factors for these diseases in PLWHA, but no studies have tested an at-home exercise program that would benefit low income people and others who do not have access to exercise facilities. This study will test the feasibility of an at-home exercise program for PLWHA and prepare for a full-scale intervention study, which may lead to a reduction in CVD risk among PLWHA.
| Condition | Intervention | Phase |
|---|---|---|
| Cardiovascular Diseases Hyperlipidemia Obesity | Behavioral: Physical Activity Group Other: Standard Care Group | Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Home-based Exercise for Management of HIV-associated Cardiovascular Disease |
Resource links provided by NLM:
Further study details as provided by University of South Carolina:
Primary Outcome Measures:
- Amount of Physical Activity [ Time Frame: 9 months ]Accelerometer data will be the primary means of determining the participants' physical activity levels. Participants will be instructed to wear the accelerometer at baseline, 4 months, and 9 months. The participants will be required to wear the accelerometer during the waking hours for seven consecutive days. Data from participants with at least four days and at least 10 hours per day will be included.
Secondary Outcome Measures:
- Cardiorespiratory Fitness [ Time Frame: 9 months ]Each participant will complete a graded exercise stress test (GXT) with indirect calorimetry. This test will be used to screen for abnormal physiological responses to exercise and for determining the participant's maximal ability to utilize oxygen (an index of cardiorespiratory fitness).
| Enrollment: | 60 |
| Study Start Date: | March 2011 |
| Study Completion Date: | July 2013 |
| Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Physical activity group
Subjects will participant in physical activity program
|
Behavioral: Physical Activity Group
9 months of home based physical activity meeting HHS recommendations for physical activity for all americans
|
|
Active Comparator: Standard care group
This group will not receive a physical activity intervention
|
Other: Standard Care Group
No intervention, the group will be followed under their standard medical care.
|
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Age 18 years and older
- Medical diagnosis of HIV-1 positive serostatus
- Sedentary lifestyle: not actively exercising ≥ 3 d•wk-1 for 20 min per session
- 18.5 kg/m2 < BMI < 40.0 kg/m2
- Stable, DHHS-approved ART regimen for previous 3 months, with HIV viral load below 75 copies/mL
- Capable of performing the required exercise regimen
- Have daily access to a telephone for approximately 10 months
- Capacity and willingness to provide informed consent and accept randomized group assignment
Exclusion Criteria:
- Individuals who have a clinical history strongly suggestive of Type 1 diabetes.
- History of serious arrythmias, cardiomyopathy, congestive heart failure, stroke or transient ischemic cerebral attacks, peripheral vascular disease with intermittent claudication, myocardial infarction, or CABG.
- Malignancies in the past 5 years, except therapeutically controlled skin cancer.
- Plans to be away > 4 weeks in the next 9 months
- Score of 5 or greater on the DAST or MAST (signifying excessive use of drugs or alcohol).
- Weight loss in excess of 10% body weight in previous 12 weeks.
- Chronic or recurrent respiratory, gastrointestinal, neuromuscular, neurological, or psychiatric conditions.
- Inflammatory-related conditions such as collagen disorders.
- Any other medical condition or disease that is life-threatening or that can interfere with or be aggravated by exercise.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01377064
Please refer to this study by its ClinicalTrials.gov identifier: NCT01377064
Locations
| United States, South Carolina | |
| The Citadel | |
| Charleston, South Carolina, United States, 29425 | |
| University of South Carolina | |
| Columbia, South Carolina, United States, 29208 | |
Sponsors and Collaborators
University of South Carolina
National Institute of Nursing Research (NINR)
More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | University of South Carolina |
| ClinicalTrials.gov Identifier: | NCT01377064 History of Changes |
| Other Study ID Numbers: |
1R21NR011281 ( U.S. NIH Grant/Contract ) |
| Study First Received: | June 8, 2011 |
| Last Updated: | December 10, 2013 |
Keywords provided by University of South Carolina:
|
HIV physical activity cardiovascular disease risk |
Additional relevant MeSH terms:
|
Cardiovascular Diseases Hyperlipidemias Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases |
ClinicalTrials.gov processed this record on July 17, 2017


IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
